Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathew S Maurer

Showing results (1-10 of 525) with videos related to

Pageof 53
Sort By:
Journal of Cardiac Failure|August 25, 2009
Heart failure with a normal ejection fraction (HFNEF): embracing complexityMathew S Maurer
Journal of the American College of Cardiology|October 18, 2003
Age: a nonmodifiable risk factor?Mathew S Maurer
Journal of the American Geriatrics Society|June 8, 2020
Norma: Participant 1,001 and the Value of Clinical ResearchMathew S Maurer
The New England Journal of Medicine|August 4, 2021
Gene Editing - A Cure for Transthyretin Amyloidosis?Mathew S Maurer
The New England Journal of Medicine|December 11, 2002
Obesity and the risk of heart failureMathew S Maurer
The American Journal of Medicine|June 21, 2015
Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear CardiologyMathew S Maurer
JACC. Cardiooncology|August 16, 2021
Call for New Therapies in Heart Failure: How Cardiology Can Learn From OncologyMathew S Maurer
Journal of Cardiac Failure|February 13, 2025
A Question in the Era of Multiple Effective Therapies for Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Is Transthyretin Biology a Driver of Disease Progression?Mathew S Maurer
The American Journal of Cardiology|November 12, 2022
Overview of Current and Emerging Therapies for Amyloid Transthyretin CardiomyopathyMathew S Maurer
Current Treatment Options in Cardiovascular Medicine|June 5, 2012
Heart failure with a normal ejection fraction: treatments for a complex syndrome?Samuel Bernard, Mathew S Maurer
Pageof 53

Showing results (1-10 of 525) with videos related to

Sort By:
Pageof 53
Journal of Cardiac Failure|August 25, 2009
Heart failure with a normal ejection fraction (HFNEF): embracing complexityMathew S Maurer
Journal of the American College of Cardiology|October 18, 2003
Age: a nonmodifiable risk factor?Mathew S Maurer
Journal of the American Geriatrics Society|June 8, 2020
Norma: Participant 1,001 and the Value of Clinical ResearchMathew S Maurer
The New England Journal of Medicine|August 4, 2021
Gene Editing - A Cure for Transthyretin Amyloidosis?Mathew S Maurer
The New England Journal of Medicine|December 11, 2002
Obesity and the risk of heart failureMathew S Maurer
The American Journal of Medicine|June 21, 2015
Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear CardiologyMathew S Maurer
JACC. Cardiooncology|August 16, 2021
Call for New Therapies in Heart Failure: How Cardiology Can Learn From OncologyMathew S Maurer
Journal of Cardiac Failure|February 13, 2025
A Question in the Era of Multiple Effective Therapies for Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Is Transthyretin Biology a Driver of Disease Progression?Mathew S Maurer
The American Journal of Cardiology|November 12, 2022
Overview of Current and Emerging Therapies for Amyloid Transthyretin CardiomyopathyMathew S Maurer
Current Treatment Options in Cardiovascular Medicine|June 5, 2012
Heart failure with a normal ejection fraction: treatments for a complex syndrome?Samuel Bernard, Mathew S Maurer
Pageof 53